We are live on ! Find out more
ATRC icon

AtriCure

160 hedge funds and large institutions have $924M invested in AtriCure in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,068% more call options, than puts

Call options by funds: $887K | Put options by funds: $28K

93% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 14

68% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 40

9% more funds holding

Funds holding: 147160 (+13)

0.14% less ownership

Funds ownership: 89.45%89.31% (-0.14%)

12% less capital invested

Capital invested by funds: $1.05B → $924M (-$130M)

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
160
Holders Change
+13
Holders Change %
+8.84%
% of All Funds
3.46%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
27
Increased
67
Reduced
40
Closed
14
Calls
$887K
Puts
$28K
Net Calls
+$859K
Net Calls Change
-$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
O
26
OppenheimerFunds
New York
$10M +$276K +9,078 +2%
Man Group
27
Man Group
United Kingdom
$9.21M +$672K +22,121 +7%
RG
28
Redmile Group
California
$8.71M +$759K +25,000 +8%
DCM
29
DAFNA Capital Management
California
$8.54M
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$8.04M +$890K +29,294 +11%
CAM
31
Cortina Asset Management
Wisconsin
$7.72M -$271K -8,922 -3%
ECM
32
Endurant Capital Management
California
$7.14M +$8.1M +266,577 New
KCM
33
Kennedy Capital Management
Missouri
$6.51M -$678K -22,334 -8%
EAM
34
Eagle Asset Management
Florida
$6.33M +$7.18M +236,499 New
Assenagon Asset Management
35
Assenagon Asset Management
Luxembourg
$6.01M +$5.64M +185,761 +483%
Citadel Advisors
36
Citadel Advisors
Florida
$5.77M +$2.37M +78,037 +57%
Charles Schwab
37
Charles Schwab
California
$5.54M +$254K +8,370 +4%
OAM
38
Oberweis Asset Management
Illinois
$5.45M -$842K -27,710 -12%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$5.32M -$783K -25,777 -11%
FI
40
Fosun International
China
$5.29M +$94.2K +3,100 +2%
Goldman Sachs
41
Goldman Sachs
New York
$5.04M +$536K +17,647 +10%
TCIM
42
TIAA CREF Investment Management
New York
$4.86M +$1.3M +42,828 +31%
Deutsche Bank
43
Deutsche Bank
Germany
$4.64M +$1.71M +56,248 +48%
KIA
44
Kopp Investment Advisors
Minnesota
$4.61M +$883K +29,087 +20%
Bank of America
45
Bank of America
North Carolina
$3.93M +$573K +18,861 +15%
Renaissance Technologies
46
Renaissance Technologies
New York
$3.48M +$3.02M +99,500 +329%
QCMC
47
Quantum Capital Management (California)
California
$3.4M +$25.7K +845 +0.7%
Two Sigma Investments
48
Two Sigma Investments
New York
$3.36M +$1.17M +38,443 +44%
Ameriprise
49
Ameriprise
Minnesota
$3.35M -$1.23M -40,389 -24%
Ohio Public Employees Retirement System (OPERS)
50
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.34M

ATRC Hedge Fund Activity: Q1 2019 in Review

160 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2019, worth a combined $924M — down 12% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ATRC positions and 14 closed out — a net gain of 13 holders — while 67 added to existing stakes and 40 trimmed.

The largest buyer was Hood River Capital Management, adding an estimated $9.87M. The largest seller was Hudson Executive Capital, cutting an estimated $26.8M.

  • 160 institutional investors held AtriCure (ATRC) as of Q1 2019, up from 147 in Q4 2018.
  • Funds reported $924M of AtriCure stock for Q1 2019, down 12% quarter-over-quarter.
  • 27 funds opened new AtriCure positions in Q1 2019 and 14 closed out, a net change of +13 holders.
  • The largest AtriCure buyer in Q1 2019 was Hood River Capital Management, an estimated $9.87M added.
  • The largest AtriCure seller in Q1 2019 was Hudson Executive Capital, an estimated $26.8M sold.

Based on aggregated 13F filings for Q1 2019.